Trial intelligence / Profile preview

Therapeutic Double-plasmid HBV DNA Vaccine in Chronic Hepatitis B

NCT01189656Phase 2Unknown

Sponsor
458th Hospital of the Chinese PLA
Start
Jan 2009
Primary completion
Nov 2010
Modality
Prophylactic Vaccines, DNA Vaccines
Countries
1
01

Overview

A Phase 2 trial of therapeutic double-plasmid hepatitis b virus deoxyribonucleic acid vaccine in Chronic Hepatitis B (CHB), sponsored by 458th Hospital of the Chinese PLA. Status: unknown.

02

Drugs

therapeutic double-plasmid hepatitis b virus deoxyribonucleic acid vaccine
03

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on NCT01189656.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01189656.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call